Vigil Neuroscience
Vigil will use the Series A funds to progress its lead pipeline candidate, a monoclonal antibody TREM2 agonist, through Phase 1 studies, advance their small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.
Domain
vigilneuro.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$40.0M
Founded
2019
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Vigil Neuroscience use?+
Vigil Neuroscience uses 14 technologies including Google Tag Manager, Material UI, Font Awesome.
What industry is Vigil Neuroscience in?+
Vigil Neuroscience operates in the Biotechnology industry.
Where is Vigil Neuroscience based?+
Vigil Neuroscience is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026